Fri 25'th May 2018
Aptevo Therapeutics Inc Stock Analysis
Technical stock analysis for Fri 25'th May 2018
Aptevo Therapeutics Inc fell by -0.55% in the last day from $5.46 to $5.43 and has now fallen 4 days in a row. The price has fallen in 7 of the last 10 days , but is still up by 8.82% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -14 620 shares and in total 73 473 shares bought and sold for approximately $398 958.
|Shorts||1.09% ( 2018-04-30 )|
Aptevo Therapeutics Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 81.77% during the next 3 months and, with 90% probability hold a price between $8.58 and $11.28 at the end of this period.
Aptevo Therapeutics Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $5.61. On a fall, the stock will find some support from the long-term average at approximately $4.62. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday May 17, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 70 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $4.98 and $4.46.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aptevo Therapeutics Inc finds support just below today's level at $4.98. If this is broken, then the next support from accumulated volume will be at $4.46 and $4.10.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.28 between high and low, or 5.29%. For the last week the stock has had a daily average volatility of 7.16%.
Our recommended stoploss: $5.04 (-7.13%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 6 days ago.)
Very Low Low Medium High Very High
Trade APVO CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder